Holding
Gilead Sciences, Inc.GILD
Biopharmaceutical company with $165B market cap and 79% gross margin. Equal-weighted at 5%; HIV and oncology franchises provide predictable cash generation.
weight · 5.00%·sector · Healthcare
SPY+0.48%QQQ+0.51%NVDA+0.03%MSFT−0.66%AAPL−1.45%GOOGL+1.11%META+0.50%AMZN−2.09%TSLA−0.54%AVGO−1.16%SPY+0.48%QQQ+0.51%NVDA+0.03%MSFT−0.66%AAPL−1.45%GOOGL+1.11%META+0.50%AMZN−2.09%TSLA−0.54%AVGO−1.16%
